Tech Center 1600 • Art Units: 1613 1615 1618
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18977210 | Ribociclib Tablet | Non-Final OA | Novartis AG |
| 18588259 | Ribociclib Tablet | Non-Final OA | Novartis AG |
| 18577357 | COMPOSITION COMPRISING A (METH)ACRYLATE COPOLYMER, AN ALKALI OR AMMONIUM SALT OF A SATURATED ALIPHATIC MONOCARBOXYLIC ACID AND SPECIFIC GLIDANTS | Non-Final OA | Evonik Operations GmbH |
| 18281704 | DRESSINGS AND METHODS FOR WOUND HEALING | Final Rejection | The Curators of the University of Missouri |
| 18544330 | TWO-STEP CLEANSING METHOD | Non-Final OA | L'OREAL |
| 17623348 | COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUND | Non-Final OA | L'OREAL |
| 18367047 | PROCESS FOR 3D BIOPRINTING UTILIZING A HYDROGEL COMPRISING A WATER-SOLUBLE ELASTIN DERIVATIVE | Non-Final OA | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG e. V. |
| 18195705 | Fatigue Resistant Porous Structure | Non-Final OA | Howmedica Osteonics Corp. |
| 18428820 | COMPOSITION FOR TREATING GOUT CONTAINING CYCLODEXTRIN-CONJUGATED POLYMER NANO-DRUG AND METHOD FOR TREATING GOUT | Final Rejection | The General Hospital Corporation |
| 18198154 | Compositions to Modify Intestinal Nutrient Absorption, Methods of Making and Uses Thereof | Non-Final OA | McMaster University |
| 18269233 | HYDROGEL FOR TREATING PRESSURE ULCERS | Final Rejection | PAUL HARTMANN AG |
| 17738764 | CONTROLLING THE SIZE OF 3D PRINTING HYDROGEL OBJECTS USING HYDROPHILIC MONOMERS, HYDROPHOBIC MONOMERS, AND CROSSLINKERS | Non-Final OA | Lung Biotechnology PBC |
| 18249338 | PEPTIDE-BASED HAIR TREATMENT | Non-Final OA | Sederma |
| 17787016 | USE OF DEHYDROASCORBIC ACID AGAINST NEMATODE INFECTION IN PLANTS | Non-Final OA | Universiteit Gent |
| 17896758 | PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE | Non-Final OA | Chugai Seiyaku Kabushiki Kaisha |
| 18682911 | Topical Compositions and Formulations with Multifunctional Actions, Including Activity Against Parasites | Non-Final OA | BIOSAFE TECHNOLOGIES, INC. |
| 18682112 | PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Non-Final OA | Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. |
| 18275257 | METHOD FOR PREPARING LOW-MOLECULAR-WEIGHT SILK SERICIN, AND COSMETIC COMPOSITION COMPRISING SERICIN PREPARED THEREBY | Final Rejection | HEWON CO., LTD. |
| 18574987 | ORAL POUCH FOR DELIVERING ACTIVE INGREDIENTS | Non-Final OA | pely-tex GmbH & Co. KG |
| 18397950 | Citrate-Based Constructs for Osteochondral Defect Repair | Non-Final OA | Acuitive Technologies, Inc. |
| 18391074 | BIOPOLYMER SCAFFOLDS AND METHODS FOR PRODUCTION OR USE THEREOF | Non-Final OA | Bionova Medical, Inc. |
| 18572725 | EXTRACTS FROM FAST GROWING MICROBES | Non-Final OA | MICROHARVEST GMBH |
| 18485087 | NATURAL COMPOSITIONS FOR USE IN TREATMENT OF GENITAL INFECTIONS | Final Rejection | Organicare LLC |
| 18242206 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | Non-Final OA | RxSight, Inc. |
| 18257869 | Methods and Compositions for the Prophylactic Treatment of SARS-CoV-2 virus (COVID-19) | Non-Final OA | MedinCell S.A. |
| 18119693 | THROMBORESISTANT COATINGS, COATED DEVICES, AND METHODS | Final Rejection | Surmodics Coatings, LLC |
| 17633678 | GINGIVAL GRAFT | Non-Final OA | CORNEAT VISION LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy